Consensus recommendations by the asian pacific society of cardiology: Optimising cardiovascular outcomes in patients with type 2 diabetes

Jack Wei Chieh Tan; David Sim; Junya Ako; Wael Almahmeed; Mark E. Cooper; Jamshed J. Dalal; Chaicharn Deerochanawong; David Wei Chun Huang; Sofian Johar; Upendra Kaul; Sin Gon Kim; Natalie Koh; Alice Pik Shan Kong; Rungroj Krittayaphong; Bernard Kwok; Bien J. Matawaran; Quang Ngoc Nguyen; Loke Meng Ong; Jin Joo Park; Yongde Peng; David K.L. Quek; Ketut Suastika; Norlela Sukor; Boon Wee Teo; Chee Kiang Teoh; Jian Zhang; Eugenio B. Reyes; Su Yen Goh

doi:10.15420/ECR.2020.52

Consensus recommendations by the asian pacific society of cardiology: Optimising cardiovascular outcomes in patients with type 2 diabetes

Jack Wei Chieh Tan
, David Sim
, Junya Ako
, Wael Almahmeed
, Mark E. Cooper
, Jamshed J. Dalal
, Chaicharn Deerochanawong
, David Wei Chun Huang
, Sofian Johar
, Upendra Kaul
, Sin Gon Kim
, Natalie Koh
, Alice Pik Shan Kong
, Rungroj Krittayaphong
, Bernard Kwok
, Bien J. Matawaran
, Quang Ngoc Nguyen
, Loke Meng Ong
, Jin Joo Park
, Yongde Peng

David K.L. Quek, Ketut Suastika, Norlela Sukor, Boon Wee Teo, Chee Kiang Teoh, Jian Zhang, Eugenio B. Reyes, Su Yen Goh

Cleveland Clinic Abu Dhabi

National Heart Centre Singapore
Singapore Health Services
Kitasato University
Monash University
Kokilaben Dhirubhai Ambani Hospital and Research Institute
Rajavithi Hospital
Veterans General Hospital-Kaohsiung Taiwan
National Yang Ming Chiao Tung University
Fooyin University Taiwan
Raja Isteri Pengiran Anak Saleha Hospital
Batra Hospital and Medical Research Centre
Korea University
Chinese University of Hong Kong
Mahidol University
Farrer Park Medical Centre
University of Santo Tomas
Hanoi Medical University
Hospital Pulau Pinang
Seoul National University
Shanghai Jiao Tong University
Pantai Hospital Kuala Lumpur
Universitas Udayana
Universiti Kebangsaan Malaysia
National University of Singapore
National Heart Institute
Chinese Academy of Medical Sciences
University of the Philippines
Singapore General Hospital

Research output: Contribution to journal › Article › peer-review

6 Scopus citations

Abstract

The Asian Pacific Society of Cardiology convened a consensus statement panel for optimising cardiovascular (CV) outcomes in type 2 diabetes, and reviewed the current literature. Relevant articles were appraised using the Grading of Recommendations, Assessment, Development and Evaluation system, and consensus statements were developed in two meetings and were confirmed through online voting. The consensus statements indicated that lifestyle interventions must be emphasised for patients with prediabetes, and optimal glucose control should be encouraged when possible. Sodium–glucose cotransporter 2 inhibitors (SGLT2i) are recommended for patients with chronic kidney disease with adequate renal function, and for patients with heart failure with reduced ejection fraction. In addition to SGLT2i, glucagon-like peptide-1 receptor agonists are recommended for patients at high risk of CV events. A blood pressure target below 140/90 mmHg is generally recommended for patients with type 2 diabetes. Antiplatelet therapy is recommended for secondary prevention in patients with atherosclerotic CV disease.

Original language	English
Article number	e14
Journal	European Cardiology Review
Volume	16
DOIs	https://doi.org/10.15420/ECR.2020.52
State	Published - 2021

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Keywords

Asia Pacific
Cardiovascular
Consensus
Glucagon-like protein 1 receptor agonist
Prediabetes
Sodium-glucose cotransporter 2 inhibitor
Type 2 diabetes

Access to Document

10.15420/ECR.2020.52

Cite this

Tan, J. W. C., Sim, D., Ako, J., Almahmeed, W., Cooper, M. E., Dalal, J. J., Deerochanawong, C., Huang, D. W. C., Johar, S., Kaul, U., Kim, S. G., Koh, N., Kong, A. P. S., Krittayaphong, R., Kwok, B., Matawaran, B. J., Nguyen, Q. N., Ong, L. M., Park, J. J., ... Goh, S. Y. (2021). Consensus recommendations by the asian pacific society of cardiology: Optimising cardiovascular outcomes in patients with type 2 diabetes. European Cardiology Review, 16, Article e14. https://doi.org/10.15420/ECR.2020.52

@article{b17e88555c134189ace43f8d6817c8b3,

title = "Consensus recommendations by the asian pacific society of cardiology: Optimising cardiovascular outcomes in patients with type 2 diabetes",

abstract = "The Asian Pacific Society of Cardiology convened a consensus statement panel for optimising cardiovascular (CV) outcomes in type 2 diabetes, and reviewed the current literature. Relevant articles were appraised using the Grading of Recommendations, Assessment, Development and Evaluation system, and consensus statements were developed in two meetings and were confirmed through online voting. The consensus statements indicated that lifestyle interventions must be emphasised for patients with prediabetes, and optimal glucose control should be encouraged when possible. Sodium–glucose cotransporter 2 inhibitors (SGLT2i) are recommended for patients with chronic kidney disease with adequate renal function, and for patients with heart failure with reduced ejection fraction. In addition to SGLT2i, glucagon-like peptide-1 receptor agonists are recommended for patients at high risk of CV events. A blood pressure target below 140/90 mmHg is generally recommended for patients with type 2 diabetes. Antiplatelet therapy is recommended for secondary prevention in patients with atherosclerotic CV disease.",

keywords = "Asia Pacific, Cardiovascular, Consensus, Glucagon-like protein 1 receptor agonist, Prediabetes, Sodium-glucose cotransporter 2 inhibitor, Type 2 diabetes",

author = "Tan, \{Jack Wei Chieh\} and David Sim and Junya Ako and Wael Almahmeed and Cooper, \{Mark E.\} and Dalal, \{Jamshed J.\} and Chaicharn Deerochanawong and Huang, \{David Wei Chun\} and Sofian Johar and Upendra Kaul and Kim, \{Sin Gon\} and Natalie Koh and Kong, \{Alice Pik Shan\} and Rungroj Krittayaphong and Bernard Kwok and Matawaran, \{Bien J.\} and Nguyen, \{Quang Ngoc\} and Ong, \{Loke Meng\} and Park, \{Jin Joo\} and Yongde Peng and Quek, \{David K.L.\} and Ketut Suastika and Norlela Sukor and Teo, \{Boon Wee\} and Teoh, \{Chee Kiang\} and Jian Zhang and Reyes, \{Eugenio B.\} and Goh, \{Su Yen\}",

note = "Publisher Copyright: {\textcopyright} RADCLIFFE CARDIOLOGY 2021",

year = "2021",

doi = "10.15420/ECR.2020.52",

language = "English",

volume = "16",

journal = "European Cardiology Review",

issn = "1758-3756",

publisher = "Radcliffe Medical Media",

}

Tan, JWC, Sim, D, Ako, J, Almahmeed, W, Cooper, ME, Dalal, JJ, Deerochanawong, C, Huang, DWC, Johar, S, Kaul, U, Kim, SG, Koh, N, Kong, APS, Krittayaphong, R, Kwok, B, Matawaran, BJ, Nguyen, QN, Ong, LM, Park, JJ, Peng, Y, Quek, DKL, Suastika, K, Sukor, N, Teo, BW, Teoh, CK, Zhang, J, Reyes, EB & Goh, SY 2021, 'Consensus recommendations by the asian pacific society of cardiology: Optimising cardiovascular outcomes in patients with type 2 diabetes', European Cardiology Review, vol. 16, e14. https://doi.org/10.15420/ECR.2020.52

TY - JOUR

T1 - Consensus recommendations by the asian pacific society of cardiology

T2 - Optimising cardiovascular outcomes in patients with type 2 diabetes

AU - Tan, Jack Wei Chieh

AU - Sim, David

AU - Ako, Junya

AU - Almahmeed, Wael

AU - Cooper, Mark E.

AU - Dalal, Jamshed J.

AU - Deerochanawong, Chaicharn

AU - Huang, David Wei Chun

AU - Johar, Sofian

AU - Kaul, Upendra

AU - Kim, Sin Gon

AU - Koh, Natalie

AU - Kong, Alice Pik Shan

AU - Krittayaphong, Rungroj

AU - Kwok, Bernard

AU - Matawaran, Bien J.

AU - Nguyen, Quang Ngoc

AU - Ong, Loke Meng

AU - Park, Jin Joo

AU - Peng, Yongde

AU - Quek, David K.L.

AU - Suastika, Ketut

AU - Sukor, Norlela

AU - Teo, Boon Wee

AU - Teoh, Chee Kiang

AU - Zhang, Jian

AU - Reyes, Eugenio B.

AU - Goh, Su Yen

PY - 2021

Y1 - 2021

N2 - The Asian Pacific Society of Cardiology convened a consensus statement panel for optimising cardiovascular (CV) outcomes in type 2 diabetes, and reviewed the current literature. Relevant articles were appraised using the Grading of Recommendations, Assessment, Development and Evaluation system, and consensus statements were developed in two meetings and were confirmed through online voting. The consensus statements indicated that lifestyle interventions must be emphasised for patients with prediabetes, and optimal glucose control should be encouraged when possible. Sodium–glucose cotransporter 2 inhibitors (SGLT2i) are recommended for patients with chronic kidney disease with adequate renal function, and for patients with heart failure with reduced ejection fraction. In addition to SGLT2i, glucagon-like peptide-1 receptor agonists are recommended for patients at high risk of CV events. A blood pressure target below 140/90 mmHg is generally recommended for patients with type 2 diabetes. Antiplatelet therapy is recommended for secondary prevention in patients with atherosclerotic CV disease.

AB - The Asian Pacific Society of Cardiology convened a consensus statement panel for optimising cardiovascular (CV) outcomes in type 2 diabetes, and reviewed the current literature. Relevant articles were appraised using the Grading of Recommendations, Assessment, Development and Evaluation system, and consensus statements were developed in two meetings and were confirmed through online voting. The consensus statements indicated that lifestyle interventions must be emphasised for patients with prediabetes, and optimal glucose control should be encouraged when possible. Sodium–glucose cotransporter 2 inhibitors (SGLT2i) are recommended for patients with chronic kidney disease with adequate renal function, and for patients with heart failure with reduced ejection fraction. In addition to SGLT2i, glucagon-like peptide-1 receptor agonists are recommended for patients at high risk of CV events. A blood pressure target below 140/90 mmHg is generally recommended for patients with type 2 diabetes. Antiplatelet therapy is recommended for secondary prevention in patients with atherosclerotic CV disease.

KW - Asia Pacific

KW - Cardiovascular

KW - Consensus

KW - Glucagon-like protein 1 receptor agonist

KW - Prediabetes

KW - Sodium-glucose cotransporter 2 inhibitor

KW - Type 2 diabetes

UR - https://www.scopus.com/pages/publications/85105579149

U2 - 10.15420/ECR.2020.52

DO - 10.15420/ECR.2020.52

M3 - Article

AN - SCOPUS:85105579149

SN - 1758-3756

VL - 16

JO - European Cardiology Review

JF - European Cardiology Review

M1 - e14

ER -

Consensus recommendations by the asian pacific society of cardiology: Optimising cardiovascular outcomes in patients with type 2 diabetes

Abstract

UN SDGs

Keywords

Access to Document

Other files and links

Fingerprint

Cite this